By Editorial TeamIn health tech, you don’t get consistent funding or stick around long enough to matter unless you’re seen as a reliable data source, the kind that gets cited. Companies that get this right are the ones constantly publishing their clinical outcomes and being completely transparent about their payer contracts which is what attracts serious investment and builds real trust with providers. So how do you actually build that kind of credibility from the ground up?
Key Takeaways
- Build one central database for all your clinical and real-world data, keeping it clean, updated, and accessible to the people who need it.
- Lock down your data governance with strict anonymization and full HIPAA compliance so you can actually share findings without getting into legal trouble.
- Create standard reporting templates for your clinical outcomes and payer contract performance to make it dead simple for outsiders to see if you’re for real.
- Co-publish research with universities and industry groups, which borrows their credibility and gets your data in front of a much wider audience.
- Be totally transparent in every data presentation, which means being upfront about the limitations of your studies and keeping an open line with investors and providers.
1. Build a Centralized, Regularly Updated Funding Database
If you want anyone to see you as a real data source, you need a single source of truth for your financial and operational info. And no, a jumble of spreadsheets doesn’t count. You need a dedicated system. For a lot of health tech startups, a flexible platform like Airtable or Monday.com works great because they’re easy to connect to other tools. The key is structuring the database with specific fields: investment rounds, investor names, funding amounts, valuation milestones, and, most importantly, the exact dates for everything.
In Airtable, for example, you’d build a base with separate tables for “Funding Rounds,” “Investors,” and “Key Performance Indicators (KPIs).” Your “Funding Rounds” table needs fields for Round Type (Seed, Series A, B, etc.), Date Closed, Amount Raised, the Lead Investor (which should link to your “Investors” table), and a Status field like “Closed” or “In Progress.” Then, in your “KPIs” table, you’d track the metrics that prove your clinical outcomes and show how your payer contracts are performing, linking them directly to the product version they relate to.
Pro Tip: Automate Data Entry Where Possible
Don’t do this by hand if you can help it. Hook up your funding database to your financial tools and CRM. Use an automation tool like Zapier or Make (formerly Integromat) to automatically pull revenue numbers from Stripe or update funding details from an investor portal right after a close. This cuts down on stupid manual errors and gives you real-time numbers, which is what you need when an investor calls out of the blue.
2. Implement Durability Analysis with Published Clinical Outcomes
Durability in this business is about proving your solution actually works over time. It’s not just about how much cash you have in the bank. This means you have to be obsessive about collecting, analyzing, and publishing your clinical outcomes. According to a 2024 report by HIMSS (Healthcare Information and Management Systems Society), investors are finally looking past the hype and demanding hard evidence of efficacy. No surprise there. This is healthcare.
To really analyze your product’s durability, you need clear metrics. If your digital therapeutic helps manage a chronic disease, you should be tracking patient adherence rates, symptom reduction on validated scales, and whether you’re reducing hospital readmissions. If it’s a diagnostic tool, you’re measuring sensitivity, specificity, and how it changes treatment decisions. You’ll need to use proper statistical software like IBM SPSS Statistics or the open-source R to run a rigorous analysis, preferably on data from well-designed randomized controlled trials (RCTs) or at least strong observational studies.
Common Mistake: Data Silos and Inconsistent Metrics
A common way companies shoot themselves in the foot is by letting clinical data get scattered across different teams or, even worse, using different metrics for the same kind of intervention. This makes any kind of aggregate analysis impossible and just tanks your credibility. You have to standardize your outcome measures from day one, maybe by adopting a recognized system like PROMIS (Patient-Reported Outcomes Measurement Information System) or a specific disease-activity score, and then centralize all that trial data in a secure, compliant system like Medidata Rave EDC.
3. Transparently Document Payer Contracts and Performance
Your long-term survival is directly tied to your payer contracts. These contracts prove you have market acceptance, a path to reimbursement, and a scalable business model. Investors want a clear line of sight to revenue, and showing you’ve successfully navigated the world of payers is the best way to give it to them. This means you have to secure the contracts and then carefully document their terms and performance.
In that central database we talked about, make a dedicated section for Payer Contracts. You’ll need fields for Payer Name, Contract Type (e.g., Fee-for-Service, Value-Based Care, Capitation), Effective Date and Expiration Date, Covered Services, and Performance Metrics. For performance, you should be tracking things like patient enrollment under the contract, claims processed, reimbursement rates, and any cost savings you generated for the payer. Present this data cleanly using a dashboarding tool like Microsoft Power BI or Tableau that’s pulling directly from your data sources.
Pro Tip: Focus on Value-Based Outcomes
The entire healthcare industry is shifting hard toward value-based care models, a trend that’s only accelerating into 2026. When you’re documenting your payer contracts, you have to show how your tech helps cut costs, improve patient outcomes, or make the payer’s life easier. Quantify those benefits. A late 2025 report from the American Hospital Association (AHA) showed that health systems overwhelmingly prefer partners who can prove a clear ROI in these value-based deals.
“As I report in a new story, UnitedHealth Group, CVS Health, and Kaiser Permanente all wrote letters opposing a medicare proposal that such remote-monitoring services be rendered directly by employees of the provider billing for it.”
4. Publish Findings in Peer-Reviewed Journals and Industry Reports
Your internal data is basically worthless until an authoritative third party validates it. Publishing your clinical outcomes in peer-reviewed medical journals is the absolute gold standard for getting that scientific validation and earning citations. You should be targeting journals that are respected in your specific field, whether that’s JAMA, The Lancet Digital Health, or the Journal of Medical Internet Research (JMIR).
Don’t just stick to academic publications, though. You should also contribute your data to industry reports and whitepapers by partnering with independent research firms or associations. For example, if you’re in diabetes management, you should be trying to work with an organization like the American Diabetes Association to publish joint findings or add your data to their big annual reports. This expands your reach and shows the market that your data has been rigorously vetted, not just spun for marketing.
Common Mistake: Delaying Publication or Over-Promising
Lots of startups sit on their data for too long, terrified a competitor will see it or that the results aren’t perfect enough. While you need to be strategic, delaying too much means you miss huge opportunities for validation that could have helped you raise your next round. At the same time, don’t publish your preliminary findings as if they’re the final word. Being transparent about your study’s limitations and what you’re still researching is how you build trust for the long haul.
5. Engage with Regulatory Bodies and Industry Standards
Your credibility as a data source lives and dies by your compliance with regulations and industry standards. This is about more than just checking the legal boxes (though you obviously have to do that). It means you should be actively involved in shaping those standards or providing data that helps inform new policies. In health tech, that often means engaging with the FDA (U.S. Food and Drug Administration), especially if you have software as a medical device (SaMD), and religiously following data privacy rules like HIPAA or GDPR.
You need to document everything: all your regulatory submissions, every approval, and your ongoing compliance work. Keep a clear audit trail of your data governance policies, security measures, and patient consent forms. This isn’t just paperwork for auditors. This documentation is your proof to investors, payers, and partners that your company is run properly and that you handle data with integrity. Getting a certification like ISO 27001 for information security is a great way to get external validation for your practices.
Pro Tip: Contribute to Standard-Setting Bodies
If you really want to be seen as a leader, get involved. Join the working groups for organizations like HL7 International or the Personal Connected Health Alliance (PCHA). Sharing your operational insights in these forums (while protecting your secret sauce, of course) helps define the future of the field and gets your company known as a serious, reliable player. This kind of proactive work often earns you a quiet endorsement from the entire industry.
Look, becoming a trusted data resource isn’t magic. It’s a grind of methodical data collection, analysis, publication, and compliance. But if you consistently prove your solution’s durability with real clinical outcomes and solid payer contracts, you’ll not only get the funding you need but also build the deep trust required to actually succeed in the healthcare market.
What specific data points are most critical for demonstrating clinical outcomes?
You need to be tracking patient enrollment and retention, outcomes from validated measures (like symptom scores or lab values), rates of adverse events, and any improvements in quality of life. The key is to collect this information systematically and report it with a proper statistical analysis.
How often should a funding database be updated?
Update it the second a big event happens, like a funding round closing or a major payer contract getting signed. For your general operational metrics and KPIs, a weekly or bi-weekly refresh is usually enough to stay current without creating a ton of extra work.
What are the best practices for ensuring data privacy and compliance when publishing outcomes?
Always de-identify patient data following regulatory rules like the HIPAA de-identification standards. You must get explicit patient consent for using their data in research and publications. Use strong security like encryption and access controls, and make sure your entire data storage and transfer process is compliant with all privacy laws.
Can early-stage companies publish clinical outcomes, or is it only for mature companies?
Yes, early-stage companies absolutely should publish results from preliminary or pilot studies, even if the scale is small. It shows you’re committed to being evidence-based and can help you secure investment for larger trials. Just be transparent that the research is in an early phase.
How can a company gain citations for its data without having a large research budget?
Team up with academic institutions. They often have the research infrastructure and publishing channels you need. Use real-world evidence from your pilot programs, which is much less expensive than a formal RCT. Present your findings at industry conferences and publish detailed whitepapers with clear methodology so others can cite your work.
